Business, Policy & Funding

FDA Approves Thermo Fisher HLA Typing Test as CDx for Immunocore Uveal Melanoma Therapy

DiaSorin, PerkinElmer, Roche, Others Nab FDA 510(k) Clearances in November

Mainz Biomed to Initiate Pivotal US Clinical Study for Colorectal Cancer Early Detection Test

Cowen Upgrades PerkinElmer Stock to Outperform

CareDx to Repurchase up to $50M of Common Stock

European Commission Outlines Intended Restorative Measures for Blocked Illumina-Grail Deal

AnPac Bio to Raise $5M in Private Placement

Top Five Articles on 360Dx Last Week: Sherlock Bio's $2M Award; Nostics' POC Testing Plans; and More

KSL Pulse Scientific to Distribute Lucira Health Home COVID-19, Flu Molecular Test in Canada

In Brief This Week: Chembio Diagnostics, Thermo Fisher Scientific, Renalytix, Theralink, More

BTIG Downgrades Oncocyte to Neutral Following News of CEO Departure

360Dx Top 30 Grows 8 Percent, Continues Upward Climb

HemoSonics Nabs FDA 510(k) for Cartridge-Based Blood Hemostasis Assay

Oxford Nanopore Technologies, Bio-Techne Partner to Develop Carrier Screening Assay

Theralink Technologies to Raise $3.1M in Private Placements

US Food and Drug Administration Releases Templates for Monkeypox Antigen Test Development

AnPac Bio Regains Compliance With Nasdaq Minimum Bid Price Requirement

PreciseDx Strikes Deal With Netherlands Pathology Lab to Study Breast Cancer Test

Sherlock Biosciences Awarded $2M by Gates Foundation for Instrument-Free Diagnostics